Bangs Laboratories
Private Company
Funding information not available
Overview
Bangs Laboratories is an established, privately-held US company that serves as a critical supplier of precision microspheres and instrument standards to the diagnostics, biopharma, and medical device industries. Its core technology platform involves the design and synthesis of uniform polymer, silica, and magnetic particles that enable biomarker detection, drug delivery, and analytical instrument calibration. With a focus on custom and OEM manufacturing, the company generates revenue by providing essential components that accelerate innovation and ensure quality control for its global customer base. Its deep technical expertise and long-standing market presence position it as a trusted partner for complex development workflows.
Technology Platform
Design, synthesis, and functionalization of uniform polymer, silica, and magnetic microspheres for use as assay reagents, separation tools, and instrument calibration standards in life science and diagnostics.
Opportunities
Risk Factors
Competitive Landscape
Bangs competes with other specialized microsphere manufacturers (e.g., Phosphorex, Corpuscular) and the life science reagents divisions of large conglomerates like Thermo Fisher Scientific, Merck KGaA (MilliporeSigma), and Agilent. Its competitive advantage lies in deep customization expertise, a broad portfolio of standards, and a strong reputation for technical support in niche applications.